Update June 2022: management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline-Reference-Cited by-同舟云学术

Update June 2022: management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline

Published:2022-06-16 Issue:2 Volume:60 Page:2200803
ISSN:0903-1936
Container-title:European Respiratory Journal
language:en
Short-container-title:Eur Respir J

Author:

Roche Nicolas,Crichton Megan L.,Goeminne Pieter C.,Cao Bin,Humbert Marc^ORCID,Shteinberg Michal^ORCID,Antoniou Katerina M.,Ulrik Charlotte Suppli^ORCID,Parks Helen,Wang Chen,Vandendriessche Thomas,Qu Jieming,Stolz Daiana,Brightling Christopher,Welte Tobias^ORCID,Aliberti Stefano^ORCID,Simonds Anita K.,Tonia Thomy,Chalmers James D.^ORCID

Funder

European Respiratory Society

Publisher

European Respiratory Society (ERS)

Subject

Pulmonary and Respiratory Medicine

Reference46 articles.

1. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

2. A Novel Coronavirus from Patients with Pneumonia in China, 2019

3. The emergence of SARS, MERS and novel SARS-2 coronaviruses in the 21st century

4. Lessons learnt from hydroxychloroquine/azithromycin in treatment of COVID-19

5. Factors associated with prolonged viral shedding and impact of lopinavir/ritonavir treatment in hospitalised non-critically ill patients with SARS-CoV-2 infection;Yan;Eur Respir J,2020

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Five sessions of hyperbaric oxygen for critically ill patients with COVID-19-induced ARDS: A randomised, open label, phase II trial;Respiratory Medicine;2024-10

2. Short- and long-term effects of imatinib in hospitalized COVID-19 patients: A randomized trial;Journal of Infection;2024-09

3. Management of severe COVID-19 in the ICU;COVID-19: An Update;2024-09-01

4. Inhaled colistimethate sodium in patients with bronchiectasis and Pseudomonas aeruginosa infection: results of PROMIS-I and PROMIS-II, two randomised, double-blind, placebo-controlled phase 3 trials assessing safety and efficacy over 12 months;The Lancet Respiratory Medicine;2024-09

5. Step-Based Dosing of Anticoagulants in COVID-19 Treatment;Cureus;2024-08-19